Investors

Genscript Biotech Corporation is a well-recognized biotechnology company. Based on our proprietary gene synthesis technology and the other technology and know-hows on life-science research and application, we have four well established major platforms including (i) a leading life-science services and products platform to provide one-stop solutions to global research communities, (ii) a biologics contract development and manufacturing organization (the “CDMO”) platform, (iii) an industrial synthetic products platform, and (iv) an integrated global cell therapy platform.

The Group has been inspired by the mission “Make People and Nature Healthier through Biotechnology” since it was founded in 2002. Our clients’ business need is the Group’s first priority and the ultimate cornerstone for pursuing its long-term development. We have been improving our clients’ competitiveness through providing our quality, fast-delivery and cost-effective services and products. Internally, we focus on streamlining our operational work flows and procedures with the aim to strive for the highest quality of end-to-end delivery. Externally, we actively promote the value of strategic collaboration with business partners with the vision to build up a healthy biotech eco-system. We would like to contribute more of our efforts to speed up the evolution of the whole biotech and biopharma industry, to realize multi-win among all the participating partners in this industry.